| scholarly article | Q13442814 |
| P2093 | author name string | Patterson M | |
| Eadie MJ | |||
| Smithurst B | |||
| Heazelwood R | |||
| P2860 | cites work | Changes in drug metabolism with increasing age: 2. phenytoin clearance and protein binding | Q34451491 |
| Effect of sodium valproate on plasma protein binding of diphenylhydantoin | Q37053483 | ||
| Plasma Albumin Concentration and Diphenylhydantoin Binding in Man | Q40324415 | ||
| Plasma protein binding interaction between phenytoin and valproic acid in vitro | Q40975699 | ||
| A comparative study of the protein binding of anticonvulsant drugs in serum of dog and man | Q41506601 | ||
| Plasma protein binding of diphenylhydantoin. Effects of sex hormones, renal and hepatic disease | Q47886443 | ||
| The effect of certain drugs on the plasma protein binding of phenytoin. | Q52728947 | ||
| Protein binding of diphenylhydantoin and desmethylimipramine in plasma from patients with poor renal function. | Q53755058 | ||
| Plasma Protein Binding of Drugs as a Function of Age in Adult Human Subjects | Q67326598 | ||
| Plasma protein binding of diphenylhydantoin in man. Interaction with other drugs and the effect of temperature and plasma dilution | Q68749158 | ||
| Rapid determination of diphenylhydantoin in blood plasma by gas-liquid chromatography | Q71422743 | ||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | phenytoin | Q410400 |
| P304 | page(s) | 423-425 | |
| P577 | publication date | 1982-03-01 | |
| P1433 | published in | British Journal of Clinical Pharmacology | Q176044 |
| P1476 | title | Plasma protein binding of phenytoin in the aged: in vivo studies | |
| P478 | volume | 13 |
| Q33882639 | Age-related changes in protein binding of drugs: implications for therapy |
| Q38323527 | Alterations in drug disposition in older adults. |
| Q40142216 | Anticonvulsant drugs. An update |
| Q41435526 | Anticonvulsant therapy in aged patients. Clinical pharmacokinetic considerations |
| Q46820934 | Clinical evaluation of plasma free phenytoin measurement and factors influencing its protein binding |
| Q33742243 | Differential kinetics of phenytoin in elderly patients. |
| Q34620862 | Do saliva concentrations predict plasma unbound theophylline concentrations? A problem re-examined |
| Q69509651 | Drug monitoring in the elderly |
| Q70644748 | Effect of age and sex on the plasma binding of acidic and basic drugs |
| Q35029493 | Fosphenytoin: clinical pharmacokinetics and comparative advantages in the acute treatment of seizures |
| Q34768828 | Free drug metabolic clearance in elderly people. |
| Q55362845 | Management of seizures in the elderly: a survey of UK geriatricians. |
| Q36791596 | Pharmacokinetics of antiepileptic drugs in elderly nursing home residents |
| Q39757956 | Plasma protein binding of drugs in the elderly |
| Q44404654 | Safety and tolerability of oxcarbazepine in elderly patients with epilepsy |
| Q60687080 | The aging liver. Drug clearance and an oxygen diffusion barrier hypothesis. |
| Q46030042 | The quantitative effect of serum albumin, serum urea, and valproic acid on unbound phenytoin concentrations in children. |
| Q38037879 | Therapeutic drug monitoring in pregnancy: rationale and current status |